How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.07 since the market last closed. This is a 2.02 ...
Le président des Républicains, Bruno Retailleau, tout juste désigné candidat à l’Elysée par les adhérents de son parti, compte supprimer « au moins » 200 000 postes dans la fonction publique s’il est ...
A good sum of two good parts. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform a relevant index, or most peers, over a market cycle on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results